For information and resources regarding returning to campus and COVID-19 please visit the university COVID-19 website

New antibody treatment could help high risk patients recover from COVID-19

A newly approved antibody therapy for COVID-19, produced by the pharmaceutical firm Eli Lilly and Company, could help high-risk patients recover from the disease as long as the virus is detected soon after infection, says Mansoor Amiji, university distinguished professor of pharmaceutical sciences and chemical engineering at Northeastern.